Clinical Research Directory
Browse clinical research sites, groups, and studies.
Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Summary
Bronchopulmonary dysplasia (BPD) is a disease that affects preterm newborn patients, preventing their lungs from developing properly. Allogeneic fetal stem mesenchymal cells from umbilical cord could reduce the prevalence of BPD in this patients.
Official title: Clinical Trial to Stablish the Security of Using Allogeneic Fetal Stem Mesenchymal Cells From Umbilical Cord, Expanded in Pre-term Patients Suffering of Bronchopulmonary Dysplasia.
Key Details
Gender
All
Age Range
1 Month - 28 Weeks
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2024-01-11
Completion Date
2026-12
Last Updated
2025-03-17
Healthy Volunteers
No
Conditions
Interventions
Control
Standard treatment
Allogenic fetal mesenchymal stem cells from umbilical cord - three infusions
3 doses of 5 million MSC will be administered
Allogenic fetal mesenchymal stem cells from umbilical cord - six infusions
6 doses of 5 million MSC will be administered
Locations (7)
Hospital Quironsalud Madrid
Pozuelo de Alarcón, Madrid, Spain
Complejo Hospitalario La Coruña
A Coruña, Spain
Hospital Clínico San Carlos
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain
Hospital Universitario Carlos Haya
Málaga, Spain
Hospital Vírgen del Rocío
Seville, Spain
Hospital Universitario y Politécnico La Fe
Valencia, Spain